For: | Kaya M, Işık D, Beştaş R, Evliyaoğlu O, Akpolat V, Büyükbayram H, Kaplan MA. Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J Hepatol 2013; 5(11): 627-634 [PMID: 24303091 DOI: 10.4254/wjh.v5.i11.627] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v5/i11/627.htm |
Number | Citing Articles |
1 |
Alessandro Mantovani, Marco Dauriz, Davide Gatti, Ombretta Viapiana, Giacomo Zoppini, Giuseppe Lippi, Christopher D. Byrne, Fabrice Bonnet, Enzo Bonora, Giovanni Targher. Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density. Alimentary Pharmacology & Therapeutics 2019; 49(4): 375 doi: 10.1111/apt.15087
|
2 |
Axel Wester, Hannes Hagström. Risk of fractures and subsequent mortality in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study. Journal of Internal Medicine 2022; 292(3): 492 doi: 10.1111/joim.13497
|
3 |
Hongliang Gao, Jing Wu, Zhenyu Sun, Furong Zhang, Tianshu Shi, Ke Lu, Dongfu Qian, Zicheng Yin, Yinjuan Zhao, Jian Qin, Bin Xue. Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1062249
|
4 |
Sikarin Upala, Veeravich Jaruvongvanich, Karn Wijarnpreecha, Anawin Sanguankeo. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. Journal of Bone and Mineral Metabolism 2017; 35(6): 685 doi: 10.1007/s00774-016-0807-2
|
5 |
Ilias D. Vachliotis, Athanasios D. Anastasilakis, Antonis Goulas, Dimitrios G. Goulis, Stergios A. Polyzos. Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. Diabetes, Obesity and Metabolism 2022; 24(9): 1702 doi: 10.1111/dom.14774
|
6 |
Stergios A. Polyzos, Athanasios D. Anastasilakis, Jannis Kountouras, Polyzois Makras, Athanasios Papatheodorou, Panagiotis Kokkoris, Grigorios T. Sakellariou, Evangelos Terpos. Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease. Journal of Bone and Mineral Metabolism 2016; 34(4): 447 doi: 10.1007/s00774-015-0687-x
|
7 |
Eleftheria Makri, Myrsini Orfanidou, Evangelia S. Makri, Antonis Goulas, Evangelos Terpos, Stergios A. Polyzos. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Journal of Clinical and Experimental Hepatology 2024; 14(3): 101353 doi: 10.1016/j.jceh.2024.101353
|
8 |
Alessandra Musio, Federica Perazza, Laura Leoni, Bernardo Stefanini, Elton Dajti, Renata Menozzi, Maria Letizia Petroni, Antonio Colecchia, Federico Ravaioli. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease. International Journal of Molecular Sciences 2023; 24(8): 7517 doi: 10.3390/ijms24087517
|
9 |
Tianyu Zhai, Qi Chen, Jing Xu, Xi Jia, Pu Xia. Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005–2014. Frontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.825448
|
10 |
Stinus Gadegaard Hansen, Charlotte Wilhelmina Wernberg, Lea Ladegaard Grønkjær, Birgitte Gade Jacobsen, Tina Di Caterino, Aleksander Krag, Claus Bogh Juhl, Mette Munk Lauridsen, Vikram V. Shanbhogue. Are Nonalcoholic Fatty Liver Disease and Bone Mineral Density Associated? — A Cross‐Sectional Study Using Liver Biopsy and Dual‐Energy X‐Ray Absorptiometry. JBMR Plus 2023; 7(3) doi: 10.1002/jbm4.10714
|
11 |
Xiong Pei, Wei Jiang, Lianchi Li, Qingmin Zeng, Chang‐Hai Liu, Ming Wang, Enqiang Chen, Taoyou Zhou, Hong Tang, Dongbo Wu. Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures. Journal of Gastroenterology and Hepatology 2024; 39(5): 847 doi: 10.1111/jgh.16448
|
12 |
Victoria Potoupni, Maria Georgiadou, Eftychia Chatzigriva, Georgia Polychronidou, Erietta Markou, Christos Zapantis Gakis, Ioanna Filimidou, Myriam Karagianni, Dimitrios Anastasilakis, Kleo Evripidou, Argyro Ftergioti, Marianthi Togkaridou, Nikolaos Tsaftaridis, Apostolos Apostolopoulos, Stergios A Polyzos. Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis. Journal of Gastroenterology and Hepatology 2021; 36(11): 3002 doi: 10.1111/jgh.15631
|
13 |
Amro M. Hassan, Mustafa Ahmed Haridy, Mohamed Z. Shoaeir, Tarek M. Abdel-Aziz, Mohamed Khairy Qura, Eglal M. Kenawy, Tarek Mohamed M. Mansour, Sameh Salaheldin Elsayed, Wael Esmat Ali, Mona Mohamed Abdelmeguid, Muhammad Abdel-Gawad. Non-alcoholic fatty liver disease is associated with decreased bone mineral density in upper Egyptian patients. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-31256-w
|
14 |
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay. Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms. Journal of Obesity & Metabolic Syndrome 2024; 33(2): 108 doi: 10.7570/jomes24004
|
15 |
Juan Du, Yan Ma, Hongmei Lang, Changquan Huang, Xingping Zhang. The association of nonalcoholic fatty liver disease with bone mineral density in type 2 diabetes. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00775-z
|
16 |
Ying‐Hao Su, Kuo‐Liong Chien, Shu‐Hua Yang, Wei‐Tso Chia, Jen‐Hau Chen, Yen‐Ching Chen. Nonalcoholic Fatty Liver Disease Is Associated With Decreased Bone Mineral Density in Adults: A Systematic Review and Meta‐Analysis. Journal of Bone and Mineral Research 2023; 38(8): 1092 doi: 10.1002/jbmr.4862
|
17 |
Tong-Hao Wang, Jian-Biao Li, Yong-Gang Tian, Jin-Xin Zheng, Xiao-Dong Li, Shu-zhang Guo. Association of TNF-α, IGF-1, and IGFBP-1 levels with the severity of osteopenia in mice with nonalcoholic fatty liver disease. Journal of Orthopaedic Surgery and Research 2023; 18(1) doi: 10.1186/s13018-023-04385-1
|
18 |
Aiyong Cui, Peilun Xiao, Zhiqiang Fan, Jinlai Lei, Shuang Han, Danlong Zhang, Xing Wei, Pengfei Wang, Yan Zhuang. Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1215790
|